Professor Jacob Sherkow will participate in a panel discussion on Pharmaceutical Innovations: Patents and the Politics of COVID-19 on September 10. Hosted by the Center for IP Research (Indiana University Maurer School of Law), Eli Lilly, and Roche, the virtual panel will discuss the role of the Bayh-Dole Act in ensuring development of, and access to, new treatments and diagnostics relating to COVID-19.